- Report
- September 2024
- 117 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- July 2024
- 112 Pages
Europe
From €3086EUR$3,450USD£2,714GBP
- Report
- July 2024
- 97 Pages
North America
From €2639EUR$2,950USD£2,320GBP
- Report
- July 2024
- 221 Pages
Global
From €4428EUR$4,950USD£3,893GBP
- Book
- October 2019
- 290 Pages
- Report
- August 2019
- 302 Pages
Global
From €4464EUR$4,990USD£3,925GBP
From €1162EUR$1,299USD£1,022GBP
- Training
- 90 Minutes
Global
- Report
- December 2023
- 100 Pages
Africa
From €1789EUR$2,000USD£1,573GBP
- Report
- December 2023
- 80 Pages
Russia
From €1342EUR$1,500USD£1,180GBP
- Report
- February 2024
- 94 Pages
Global
From €3500EUR$4,191USD£3,185GBP

The biocompatibility market is a subset of the biotechnology industry that focuses on the safety and compatibility of materials used in medical devices and implants. It involves the testing of materials to ensure they are non-toxic, non-allergenic, and non-carcinogenic. The market also includes the development of materials that are biodegradable and biocompatible, as well as the development of methods to assess the safety of materials.
The biocompatibility market is driven by the increasing demand for medical devices and implants, as well as the need for safer and more effective materials. The market is also driven by the increasing demand for personalized medicine, as well as the need for materials that are compatible with the human body.
Some companies in the biocompatibility market include Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Merck KGaA, Thermo Fisher Scientific, Inc., and Sigma-Aldrich Corporation. Show Less Read more